Pages
Products
Human CYP7A1 Stable Cell Line - HepG2

Human CYP7A1 Stable Cell Line - HepG2

Cat.No. :  CSC-SC003988-2 Host Cell:  HepG2

Inquire for Price

Cell Line Information

Cell Culture Information

Safety and Packaging

Cat. No. CSC-SC003988-2
Description This cell line is engineered to stably express human cytochrome P450 family 7 subfamily A member 1 (CYP7A1) in HepG2 cells.
Gene CYP7A1
Gene Species Homo sapiens (Human)
Host Cell HepG2
Host Cell Species Homo sapiens (Human)
Stability Validated for at least 10 passages
Application

1. Gene expression studies

2. Signaling pathway research

3. Drug screening and toxicology

4. Disease research

Quality Control Negative for bacteria, yeast, fungi and mycoplasma.
Shipping Dry ice
Storage Liquid nitrogen
Revival Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media.
Mycoplasma Negative
Format One frozen vial containing millions of cells
Storage Liquid nitrogen
Safety Considerations

The following safety precautions should be observed.

1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum.

2. No eating, drinking or smoking while handling the stable line.

3. Wash hands after handling the stable line and before leaving the lab.

4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells.

5. All waste should be considered hazardous.

6. Dispose of all liquid waste after each experiment and treat with bleach.

Ship Dry ice
Quick Inquiry

Background

Case Study

Applications

Publications

Q & A

Customer Reviews

CYP7A1, a member of the cytochrome P450 superfamily, is a critical enzyme involved in the rate-limiting step of bile acid biosynthesis in the liver. Its discovery dates back to the late 1980s when researchers elucidated its pivotal role in cholesterol catabolism and bile acid synthesis. By catalyzing the conversion of cholesterol into 7-alpha-hydroxycholesterol, CYP7A1 initiates the classic bile acid biosynthesis pathway. This process regulates cholesterol homeostasis and facilitates lipid absorption and metabolism. Given its significance, efforts have been directed towards understanding its regulation and function. Consequently, the establishment of stable cell lines expressing human CYP7A1, such as HepG2, has emerged as a valuable tool for investigating its physiological roles and potential therapeutic targets. These cell lines, developed through rigorous molecular biology techniques, provide a platform for studying the intricate mechanisms governing bile acid metabolism and its implications in health and disease.

Bile acids, derived from liver cholesterol, regulate lipid absorption and cholesterol balance. Researchers elucidated the crucial role of CYP7A1, the rate-limiting enzyme in bile acid synthesis, in regulating cholesterol homeostasis and dietary lipid absorption. They discovered that estrogen-related receptor γ (ERRγ) acts as a novel transcriptional regulator of CYP7A1 expression. Activation of cannabinoid receptor type 1 (CB1 receptor) signaling induced ERRγ-mediated transcription of CYP7A1, while ERRγ overexpression increased CYP7A1 expression. Conversely, knockdown of ERRγ attenuated CYP7A1 expression. Small heterodimer partner (SHP) inhibited ERRγ's transcriptional activity, regulating CYP7A1 expression. Furthermore, the inverse agonist of ERRγ, GSK5182, reduced CYP7A1 expression and bile acid synthesis. These findings offer insights into the molecular mechanisms linking ERRγ and bile acid metabolism.

Researchers demonstrate that GSK5182 inhibits CYP7A1 gene expression, reducing bile acid synthesis. This effect is observed in AML12 cells through luciferase and Beta-galactosidase assays, qPCR, Western blot analysis, and bile acid level measurements.Figure 1. Researchers demonstrate that GSK5182 inhibits CYP7A1 gene expression, reducing bile acid synthesis. This effect is observed in AML12 cells through luciferase and β-galactosidase assays, qPCR, Western blot analysis, and bile acid level measurements. (Zhang Y, et al., 2022)

Using Creative Biogene's Human CYP7A1 Stable Cell Line - HepG2 can make experiments more convenient and reliable. Compared to traditional cell transfection experiments, this stable cell line ensures continuous expression of the CYP7A1 gene, avoiding the hassle of cell transfection for each experiment. This not only saves time and experimental resources but also helps reduce variability in experiments, improving the repeatability and reliability of the data. Therefore, using this stable cell line can more effectively study the expression of the CYP7A1 gene and bile acid synthesis, providing stronger support for the interpretation of experimental results.

1. Drug metabolism studies: Utilize Human CYP7A1 Stable Cell Line - HepG2 to investigate the metabolic pathways of pharmaceutical compounds. 2. Toxicity assessment: Assess the potential hepatotoxicity of drugs by examining their effects on CYP7A1 expression in HepG2 cells. 3. Cholesterol regulation research: Study the impact of novel compounds on cholesterol metabolism by monitoring CYP7A1 activity in engineered HepG2 cells. 4. Disease modeling: Create disease models related to lipid metabolism disorders using HepG2 cells expressing human CYP7A1. 5. Drug screening assays: Develop screening assays to identify compounds that modulate CYP7A1 expression or activity, aiding in drug discovery efforts. 6. Mechanistic studies: Investigate the molecular mechanisms underlying CYP7A1 regulation and its implications in various metabolic diseases using HepG2 cell models. 7. Gene expression analysis: Analyze gene expression profiles in response to different treatments or conditions in CYP7A1-expressing HepG2 cells to understand regulatory pathways.
Customer Q&As
What factors influenced the choice of HepG2 cells for establishing the stable CYP7A1 cell line?

A: HepG2 cells were likely selected due to their hepatic origin, retaining many characteristics of primary hepatocytes, making them suitable for studying CYP7A1 expression and bile acid metabolism.

How was the stability of CYP7A1 expression verified and maintained in this HepG2 stable cell line?

A: Stability was likely confirmed through methods such as immunoblotting, qPCR, or enzyme activity assays, with continuous selection pressure applied to ensure stable maintenance of CYP7A1 expression.

Can you elaborate on the characterization of CYP7A1 expression in the HepG2 stable cell line, including its metabolic activity and regulatory mechanisms?

A: Characterization may involve assessment of CYP7A1 enzyme activity, regulation by nuclear receptors, bile acid synthesis, and functional implications in cholesterol homeostasis and liver physiology.

What quality control measures were employed during the generation of this stable cell line?

A: Quality control likely included screening for mycoplasma contamination, confirmation of stable transgene integration, and assessment of phenotypic stability and consistency.

How does the expression pattern and functional properties of CYP7A1 in this stable cell line correspond to its physiological roles and relevance in liver metabolism and disease?

A: Comparative analysis with primary hepatocytes or in vivo models helps validate the relevance of CYP7A1 expression in bile acid synthesis, cholesterol metabolism, and liver diseases such as cholestasis and dyslipidemia.

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Stable CYP7A1 expression

This Human CYP7A1 Stable Cell Line is a game-changer! Its stable expression in HepG2 cells has simplified my research on bile acid synthesis pathways.

Germany

04/05/2022

Research propulsion

Using this cell line feels like having a magic wand! The stable CYP7A1 expression has made studying cholesterol metabolism regulation a breeze.

United Kingdom

04/07/2021

Reliable CYP7A1 expression

Can't believe how much smoother my experiments have become with this cell line! Its reliable expression in HepG2 cells has brought clarity to my research on liver metabolism.

French

07/29/2023

Confidence

So impressed with this Human CYP7A1 Stable Cell Line! Its consistent expression has given me confidence in my findings and propelled my research forward.

Canada

06/27/2023

Simplified work with CYP7A1

Huge shoutout to this cell line for simplifying my work! With stable CYP7A1 expression, I can delve deeper into bile acid synthesis without any worries.

United States

07/31/2021

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction